Unknown

Dataset Information

0

Single-chain V?V? T-cell receptors function without mispairing with endogenous TCR chains.


ABSTRACT: Transduction of exogenous T-cell receptor (TCR) genes into patients' activated peripheral blood T cells is a potent strategy to generate large numbers of specific T cells for adoptive therapy of cancer and viral diseases. However, the remarkable clinical promise of this powerful approach is still being overshadowed by a serious potential consequence: mispairing of the exogenous TCR chains with endogenous TCR chains. These 'mixed' heterodimers can generate new specificities that result in graft-versus-host reactions. Engineering TCR constant regions of the exogenous chains with a cysteine promotes proper pairing and reduces the mispairing, but, as we show here, does not eliminate the formation of mixed heterodimers. By contrast, deletion of the constant regions, through use of a stabilized V?/V? single-chain TCR (scTv), avoided mispairing completely. By linking a high-affinity scTv to intracellular signaling domains, such as Lck and CD28, the scTv was capable of activating functional T-cell responses in the absence of either the CD3 subunits or the co-receptors, and circumvented mispairing with endogenous TCRs. Such transduced T cells can respond to the targeted antigen independent of CD3 subunits via the introduced scTv, without the transduced T cells acquiring any new undefined and potentially dangerous specificities.

SUBMITTER: Aggen DH 

PROVIDER: S-EPMC3321103 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Aggen D H DH   Chervin A S AS   Schmitt T M TM   Engels B B   Stone J D JD   Richman S A SA   Piepenbrink K H KH   Baker B M BM   Greenberg P D PD   Schreiber H H   Kranz D M DM  

Gene therapy 20110714 4


Transduction of exogenous T-cell receptor (TCR) genes into patients' activated peripheral blood T cells is a potent strategy to generate large numbers of specific T cells for adoptive therapy of cancer and viral diseases. However, the remarkable clinical promise of this powerful approach is still being overshadowed by a serious potential consequence: mispairing of the exogenous TCR chains with endogenous TCR chains. These 'mixed' heterodimers can generate new specificities that result in graft-v  ...[more]

Similar Datasets

| S-EPMC3007160 | biostudies-other
| S-EPMC3391256 | biostudies-literature
2021-12-15 | GSE182870 | GEO
| S-EPMC6319330 | biostudies-literature
| S-EPMC7640589 | biostudies-literature